“My name is Zoe Sigman, and I’m the Program Director at Project CBD, an educational nonprofit focused on cannabis science & medicine. Ten years ago, we introduced CBD to the medical cannabis community in California. It spread like wildfire and has become the hugely popular phenomenon that it is today.
In June 2018, the Food and Drug Administration (FDA) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. Six months later, Congress passed the Farm Bill, which legalized the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction.
Project CBD responds to the Food and Drug Administration’s call for statements on the use of CBD.
In December of 2016, the DEA announced that it is implementing new rules that may portend a crackdown on CBD oil products. Misinformation claiming cannabidiol was legal was promoted by numerous online businesses. Educate yourself about the situation and what you can do.
Kratom is an unique medicinal herb with pain relieving properties that function as an opiate substitute. So why is the FDA and the DEA trying to block people’s access to it by making it a Schedule 1 drug?